Astellas Pharma at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Astellas Pharma brings 2 presentations to SITC 2026 in Phoenix. Its program centres on antibody-drug conjugates that carry two drug payloads at once, aimed at TROP2 and B7H3. The most distinctive one pairs tumor-cell killing with immune stimulation through the STING pathway to produce lasting responses.
| Organization | SITC 2026 Attendance |
|---|---|
Astellas Pharma Tokyo, Japan | |
Japanese pharmaceutical company with medicines in oncology, urology and immunology. | Talk Thu Nov 5 1:55pm–2:05pm |
Instantly find 20 buyers from Astellas Pharma
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction